BioCentury on BioBusiness,
How $5B Novartis Animal Health acquisition advances Lilly's growth agenda
Monday, April 28, 2014
Lilly and Co.'s acquisition of Novartis
AG's animal health unit is the latest and largest in a series of animal
health investments by Lilly, which have yielded a veterinary business with
comparable profit margins to its human therapeutic side. The Novartis deal will
enrich Lilly's Elanco Animal Health's companion animal offerings, add new areas
like aquaculture and increase its commercial presence in Europe and emerging
While Novartis and GlaxoSmithKline
plc swapped assets last week to build up their strong areas and offload
those where they can't be leaders, Lilly's portion of the transaction is solely
bullish (see Cover Story).
words displayed of
To read this article, you must be an Archives subscriber. Please choose one of the options below.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Whether you want an individual subscription or need a global group license, we have the products,
the experience and the customer support that biopharma executives, researchers, investors, service providers,
and industry stakeholders have trusted for nearly two decades.
Let our Subscriber Services team customize the best intelligence package available in the industry to meet your needs.
Free Trial Subscription 4 Weeks of Access
BioCentury's Weekly Business Intelligence Journal
Get a 4-week free trial subscription to BioCentury.
Get 4 Weeks Free
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]